All stocks / BTCY
BIOTRICITY INC. BTCY
Biotricity (BTCY): a late 10-Q notice in August 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- BIOTRICITY INC
- Market tier
- OTCQB
- Trading status
- Active
- Last trade
- Nov 16
- Website
- biotricity.com
News headlines
The financial report, and what it means
Annual figures to 2026-03-31- Revenue
- $15,998,239
- Net loss
- ($2,404,139)
It spends more than it earns
Under strainCustomers paid it $16 million in the year. It lost $2.4 million. For every $1 that came in, about $1.15 went out.
- Cash and cash equivalents
- $149,789
- Net cash used in operating activities
- ($718,955)
The cash could run out soon
Under strainIt had $149,789 in the bank and used about $59,913 a month. At that pace the money lasts about 3 months unless it borrows or sells more shares.
- Total assets
- $6,446,488
- Total liabilities
- $39,408,954
It owes more than it owns
Under strainEverything the company owns adds up to $6.4 million. Its debts and unpaid bills add up to $39.4 million. That is about $6.11 owed for every $1 owned.
What this adds up to
3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.
Signals
Estimated float about 21,631,493 shares as of 2026-11-16: 21,631,493 outstanding minus 0 held by 0 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Filed NT 10-Q on 2026-08-17: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Filed NT 10-K on 2026-06-29: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
| 2026-11-16 | 10-Q | 10-Q |
| 2026-11-12 | SCHEDULE 13G/A | |
| 2026-10-07 | RW | RW |
| 2026-09-28 | 8-K | 8-K |
| 2026-08-19 | 10-Q | 10-Q |
| 2026-08-17 | NT 10-Q | NT 10-Q |
| 2026-08-14 | SCHEDULE 13G/A | |
| 2026-07-14 | 10-K | 10-K |
| 2026-06-29 | NT 10-K | NT 10-K |
| 2026-06-16 | DEF 14C | DEF 14C |
| 2026-05-29 | PRE 14C | PRE 14C |
| 2026-05-12 | SCHEDULE 13G/A |
Common questions about BTCY
Does BTCY file reports with the SEC?
Yes. Biotricity files with the SEC under company number 0001630113. The most recent filing we hold is a 10-Q dated 2026-11-16.
Source recordHow many BTCY shares are outstanding?
21,631,493 shares as of 2026-11-16, as reported to the SEC.
Source recordHas BTCY filed reports late?
Yes. In the last 12 months it filed 2 late-filing notices, most recently a NT 10-Q on 2026-08-17. A notice means a report was not ready on time; check whether the report followed.
Source recordIs Biotricity making money?
Customers paid it $16 million in the year. It lost $2.4 million. For every $1 that came in, about $1.15 went out. (Annual figures to 2026-03-31. Facts from the company's own report, not a recommendation.)
Source record